Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01038 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 1424.05 36.40 (2.62%) | NSE 1418.90 32.70 (2.36%) | Trade | Add

BSE Live

Dec 31, 15:41

1424.05 36.40 (2.62%)

Volume

AVERAGE VOLUME

5-Day

20,736

10-Day

12,606

30-Day

32,106

18,531

Prev. Close

1387.65
Open Price

1373.30

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1424.05 (4)

NSE Live

Dec 31, 15:52

1418.90 32.70 (2.36%)

Volume

AVERAGE VOLUME

5-Day

194,271

10-Day

157,264

30-Day

206,088

337,071

Prev. Close

1386.20
Open Price

1386.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1418.90 (276)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Ipca Laboratories (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
Per Share Ratios
Basic EPS (Rs.)	47.77	35.01	18.97	15.42	7.38
Diluted EPS (Rs.)	47.73	35.01	18.97	15.42	7.38
Cash EPS (Rs.)	65.05	49.58	33.39	29.77	20.56
Book Value [ExclRevalReserve]/Share (Rs.)	288.18	248.35	213.04	194.55	179.02
Book Value [InclRevalReserve]/Share (Rs.)	288.18	248.35	213.04	194.55	179.02
Revenue from Operations/Share (Rs.)	367.92	298.63	258.14	250.09	227.19
PBDIT/Share (Rs.)	77.06	59.32	39.34	37.03	24.71
PBIT/Share (Rs.)	60.40	44.89	25.26	23.33	11.77
PBT/Share (Rs.)	59.10	43.39	23.36	21.42	9.24
Net Profit/Share (Rs.)	48.39	35.14	19.31	16.07	7.62
NP After MI And SOA / Share (Rs.)	47.99	35.21	18.97	15.42	7.38
Profitability Ratios
PBDIT Margin (%)	20.94	19.86	15.24	14.80	10.87
PBIT Margin (%)	16.41	15.03	9.78	9.32	5.18
PBT Margin (%)	16.06	14.53	9.04	8.56	4.06
Net Profit Margin (%)	13.15	11.76	7.47	6.42	3.35
NP After MI And SOA Margin (%)	13.04	11.78	7.34	6.16	3.24
Return on Networth/Equity (%)	16.71	14.24	8.90	7.92	4.12
Return on Capital Employed (%)	19.40	16.42	7.69	6.47	3.18
Return on Assets (%)	11.52	9.77	5.81	4.91	2.39
Total Debt/Equity (X)	0.11	0.11	0.18	0.22	0.30
Asset Turnover Ratio (%)	88.38	82.91	79.12	79.71	73.67
Liquidity Ratios
Current Ratio (X)	2.15	2.17	1.93	1.82	1.67
Quick Ratio (X)	1.16	1.19	1.06	0.90	0.81
Inventory Turnover Ratio (X)	3.51	3.52	3.70	3.58	3.42
Dividend Payout Ratio (NP) (%)	16.67	2.84	5.27	0.00	13.54
Dividend Payout Ratio (CP) (%)	12.37	2.01	3.02	0.00	4.92
Earnings Retention Ratio (%)	83.33	97.16	94.73	0.00	86.46
Cash Earnings Retention Ratio (%)	87.63	97.99	96.98	0.00	95.08
Coverage Ratios
Interest Coverage Ratios (%)	46.25	30.06	13.27	12.23	4.66
Interest Coverage Ratios (Post Tax) (%)	46.25	30.06	13.27	12.23	4.66
Valuation Ratios
Enterprise Value (Cr.)	17,785.27	12,498.93	8,587.32	8,359.87	7,810.03
EV/Net Operating Revenue (X)	3.83	3.31	2.64	2.65	2.72
EV/EBITDA (X)	18.27	16.68	17.30	17.89	25.05
MarketCap/Net Operating Revenue (X)	3.77	3.29	2.54	2.49	2.55
Retention Ratios (%)	83.32	97.15	94.72	0.00	86.45
Price/BV (X)	4.83	3.98	3.07	3.20	3.24
Price/Net Operating Revenue	3.77	3.29	2.54	2.49	2.55
Earnings Yield	0.03	0.04	0.03	0.02	0.01